Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 61 results for "biocon"

Biocon: Monetisation of drug pipeline in emerging markets to boost earnings
Business Standard

Biocon: Monetisation of drug pipeline in emerging markets to b...

Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the ... Business Standard, 1 day ago

73 images for biocon

Business Standard, 1 day ago
Business Standard, 1 day ago
Money Control, 1 week ago
Money Control, 6 days ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Sify, 3 weeks ago
Money Control, 3 weeks ago
Business Standard, 1 month ago
Money Control

Biocon partner Mylan enters pact with Fujifilm to commercialise Humira biosimilar in Europe

Mylan said its partner Biocon will receive economic benefit through this collaboration.
 Money Control1 week ago Biocon advances as Mylan enters in pact with Fujifilm  Business Standard1 week ago We expect roll out of insulin glargine in Europe to start in second half of 2018, says Biocon  Money Control3 weeks ago Biocon, Mylan get European Commission nod to market biosimilar insulin glargine  Money Control3 weeks ago
Money Control

Morgan Stanley overweight on Biocon, sees significant upside from its biosimilar pipeline

The house is of the view that H2 seems to be strong for the company and Mylan with monetisation prospects of biosimilar pipeline improving. The firm expects significant upside from its biosimilar pipeline in 2019-2021.
 Money Control6 days ago

Biocon Ltd is up for a third straight session in a row

e stock is quoting at Rs 620.05, up 1.86% on the day as on 12:54 IST on the NSE. Biocon Ltd is up 68.33% in last one year as compared to a 13.04% gain in NIFTY and a 15.07% gain in the Nifty Pharma index. Biocon Ltd is up for a third straight session in a ...
 Business Standard1 week ago Biocon Ltd leads gainers in 'A' group  Business Standard1 month ago

Indian Share Markets Open Flat; Metal & Energy Stocks Drag

Posted by Equitymaster Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.5% while the Hang Seng is down 0.1%. The Nikkei 225 is trading flat. Meanwhile, Wall Street stocks fell on Wednesday as possible ...
 Equitymaster.com1 week ago Firm US Markets; Sun Pharma, Software Stocks & Other Top Cues to Sway the Markets Today  Equitymaster.com1 month ago Market Outlook: Earnings, oil prices to drive equity markets  Sify2 months ago
Money Control

Biocon gains 2% on European Commission, TGA Australia approval

Semglee 100 units/ml 3 mL prefilled disposable pen for people with diabetes, is the first biosimilar from Biocon and Mylan#39;s joint portfolio to be approved in Europe.
 Money Control3 weeks ago Mylan and Biocon receive approval for Semglee Biosimilar Insulin Glargine  Business Standard3 weeks ago USFDA completes pre-approval inspection at Biocon Malyasia  Business Standard1 month ago

Biocon gets 6 USFDA observations for Malaysia facility, shares down 2%

Shares of Biocon were trading at Rs 561.30 apiece in the morning trade, down 1.93 per cent, from the previous close on BSE Last Updated at February 21, 2018 11:27 IST Biotechnology major Biocon on Wednesday said the US health regulator has made six ...
 Business Standard1 month ago Biocon falls over 3% as co gets 6 observations at Malaysia facility  Money Control1 month ago Biocon slips after USFDA inspection at Malaysia facility  Business Standard1 month ago
Business Standard

USFDA approvals can unlock $1 bn biosimilar business for Biocon in the US

We have at least a five-year head start in biosimilars compared with other Indian drugmakers, says Mazumdar-Shaw Ari Altstedter | Bloomberg Last Updated at March 20, 2018 10:11 IST Biocon's facility. Photo: Company's website Biocon Ltd, the only Indian ...
 Business Standard1 month ago

Biocon stocks plunge, after company reports 46 percent decline in profits

Bengaluru: Shares of pharma and biotech major, Biocon slumped after the company reported a Rs 92 crore consolidated net profit for the third quarter of 2017-18, a 46 per cent decline annually from Rs 171 crore in the same period a year ago. The stocks dipped ...
 Sify2 months ago Biocon tumbles after weak Q3 results  Business Standard2 months ago Biocon Q3 net profit plunges 46% to Rs 920 million on higher interest  Business Standard2 months ago Syngene Q3 net profit up 11% at Rs 82 crore  Money Control2 months ago
Business Standard

Eight Indian women in Forbes billionaires list 2018; Savitri Jindal richest

Biocon chief Kiran Mazumdar-Shaw is the second richest Indian woman Press Trust of India | New Delhi Last Updated at March 7, 2018 16:46 IST Eight Indian women have featured in this year's Forbes list of the world's richest people. Forbes' 2018 'World's ...
 Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less